AUTONOMIC PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE
直立不耐受的自主病理生理学
基本信息
- 批准号:6242728
- 负责人:
- 金额:$ 18.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-20 至 1998-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Orthostatic intolerance is the most frequently encountered
dysautonomia and the cause of much disability. As many as 500,000
Americans are affected by it. Yet it is one of the least studied diseases.
There is no established therapy. Its etiology is poorly understood, but is
assumed to be heterogeneous.
In this project, we propose a potential mechanism for orthostatic
intolerance, which may represent the pathophysiology relevant to a
significant portion or perhaps a majority of this patient population. We
test the hypothesis that the subgroup of these patients have partial or
distal dysautonomia, giving rise to a clinical syndrome of blood pooling,
salt wasting, inadequate plasma volume, and attempted but inadequate
compensation of a relatively intact proximal autonomic innervation of the
heart.
To prove that a partial or distal dysautonomia causes orthostatic
intolerance in some patients, several criteria must be met. First, there
must be evidence of local impairment in the sympathetic noradrenergic
system, and this evidence should be based on biochemical, physiological
and pharmacological criteria. Second, the impairment should be greater at
distal (lower extremity) sites than at proximal (cardiac) sites. Third,
central autonomic control should be preserved. Finally, denervation
hypersensitivity should be greatest in the areas where the dysautonomia is
most extensive.
The unexpected finding that suppressed plasma renin levels occur in
these patients, largely in direct proportion to the hypovolemia, and, in
spite of orthostatic tachycardia and raised plasma norepinephrine levels,
could be the crucial impairment that results in the hypovolemia. Since the
initial submission, we have much new preliminary data congruent with our
hypothesis (see figures 1,2,12,13 and the designated sections of text.
Successful mechanistic characterization of this disorder should lead
to improved diagnosis and the rational design of therapy in a significant
portion of individuals presenting with previously unexplained pathological
orthostatic intolerance.
直立性不耐受是最常见的
自主神经功能障碍和许多残疾的原因。多达50万
美国人深受其害,但它是研究最少的疾病之一。
没有既定的治疗方法。其病因学知之甚少,但
假设是异质的。
在这个项目中,我们提出了一个潜在的机制,直立
不耐受,这可能代表了与
很大一部分或可能是大多数患者。我们
检验这些患者的亚组具有部分或
远端自主神经功能障碍,引起血液汇集的临床综合征,
盐浪费,血浆容量不足,尝试但不充分
的相对完整的近端自主神经支配的补偿
心
证明部分或远端自主神经功能障碍导致直立性
在某些患者中,必须满足几个标准。一是
必须是交感神经去甲肾上腺素能神经系统局部受损的证据
系统,而这一证据应基于生物化学,生理学
和药理学标准。第二,减值应大于
远端(下肢)部位比近端(心脏)部位更明显。第三、
应该保留中央自主控制。 最后,去神经
超敏反应应该是最大的地区,其中植物神经功能障碍是
最广泛的。
这一意想不到的发现,抑制血浆肾素水平发生在
这些患者,很大程度上与低血容量成正比,
尽管直立性心动过速和血浆去甲肾上腺素水平升高,
可能是导致血容量不足的关键损伤。以来
初步提交,我们有许多新的初步数据与我们的
假设(见图1、2、12、13和正文指定部分)。
这种疾病的成功机制特征应该导致
改善诊断和合理设计治疗,
出现先前无法解释的病理性
立位不耐受
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID HERLIE ROBERTSON其他文献
DAVID HERLIE ROBERTSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID HERLIE ROBERTSON', 18)}}的其他基金
AUTONOMIC DETERMINANTS OF ORTHOSTATIC TOLERANCE
直立性耐受力的自主决定因素
- 批准号:
8147945 - 财政年份:2010
- 资助金额:
$ 18.83万 - 项目类别:
Autonomic Rare Diseases Clinical Research Consortium
自主神经罕见疾病临床研究联盟
- 批准号:
8136818 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:
Autonomic Rare Diseases Clinical Research Consortium
自主神经罕见疾病临床研究联盟
- 批准号:
7680534 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:
training - Autonomic Rare Diseases Clinical Research Consortium
培训 - 自主神经罕见疾病临床研究联盟
- 批准号:
7901217 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:
Autonomic Rare Diseases Clinical Research Consortium
自主神经罕见疾病临床研究联盟
- 批准号:
8327851 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:
Autonomic Rare Diseases Clinical Research Consortium
自主神经罕见疾病临床研究联盟
- 批准号:
8150403 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:
Autonomic Rare Diseases Clinical Research Consortium
自主神经罕见疾病临床研究联盟
- 批准号:
8765054 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:
Autonomic Rare Diseases Clinical Research Consortium
自主神经罕见疾病临床研究联盟
- 批准号:
9146407 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 18.83万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 18.83万 - 项目类别: